Equity Research firms currently have a positive stance on shares of The Female Health Company (NASDAQ:FHCO). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $5.40 on a short term basis.
At the time of writing, the stock was trading at $1.18. This represents a change from the opening price of -0.84%. In terms of performance, year to date, the stock is -17.93%. The monthly stock performance comes in at -9.16%. For the quarter, shares are performing at -6.30%. Weekly performance analysis shows the equity at 1.71%.
In taking a look at technical levels, shares are trading -8.76% away from the 50 day simple moving average and -19.33% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -57.09% away from it’s 52- week high and 2.61% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, The Female Health Company’s RSI stands at 41.03. In looking at volatility levels, the shares saw weekly volatility of 4.27% and 4.70% over the past month.